NCT01168895: Study in COPD (Chronic Obstructive Pulmonary Disease) Subjects to Investigate Safety, Tolerability, and Pharmacokinetics of Ciprofloxacin After Single Dose Inhalations of 50 mg and 75 mg Ciprofloxacin Inhalation Powder |
|
|
| Completed | 1 | 12 | Europe | Cipro Inhale (Ciprofloxacin, BAYQ3939) | Bayer | Infection, Pulmonary Disease, Chronic Obstructive | 09/10 | 09/10 | | |
